[1]
Likmeta, M., Shkoza, A., Zguri, L. and Kraja, B. 2015. CHRONIC HEPATITIS C WITH SIGNIFICANT MORBIDITY AND END-ORGAN DAMAGE DEVELOPMENT DURING PEG-INTERFERON ALPHA-2A/RIBAVIRIN THERAPY. European Scientific Journal, ESJ. 11, 18 (Jun. 2015).